EWZ News Alert Brazil Index MSCI Ishares (EWZ) 39.13 12/04/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Brazil Index MSCI Ishares (EWZ) 39.13 $EWZ

Where Are The Weakest Links Among Commodity Exporters?
Mehran Nakhjavani - Seeking Alpha - Thu Dec 04, 6:52AM CST
Commodity-dependent economies are by nature volatile. During booms, their financial assets appreciate as investors become convinced of their long-term potential, driven by the strong, secular global demand for their exports. Their growth rates rise,...
BZQ: 75.04 (+2.60), INDY: 31.84 (+0.09), AUSE: 53.88 (+0.10), EWC: 29.46 (-0.57), UMX: 36.94 (unch), UBR: 32.40 (-1.35), RUSS: 22.49 (+1.60), INP: 74.49 (-0.18), EPU: 33.24 (-0.22), IDX: 25.26 (+0.07), INDL: 99.97 (-0.34), EWA: 23.54 (+0.06), FAUS: 29.06 (unch), PIN: 22.52 (+0.01), ECH: 41.11 (+0.02), ERUS: 14.25 (-0.37), INDA: 32.09 (+0.09), NORW: 13.47 (-0.14), FBZ: 16.61 (-0.41), BRZU: 10.73 (-0.63), DBBR: 13.65 (-0.21), FCAN: 32.36 (-0.93), QCAN: 59.57 (+0.54), EWW: 61.96 (-0.52), DBMX: 25.07 (+0.03), SMK: 20.57 (unch), RUSL: 6.24 (-0.52), INXX: 13.59 (-0.04), ENZL: 40.48 (+0.19), RBL: 18.06 (-0.53), QMEX: 26.18 (-0.68), EPI: 23.39 (-0.07), RSX: 18.66 (-0.51), QAUS: 54.97 (+0.08), EIDO: 27.76 (+0.12), EWZ: 39.13 (-0.74), ENOR: 24.74 (-0.30)

Look for Shares of iShares MSCI Brazil Index Fund to Potentially Rebound after Yesterday's 4.13% Sell Off
Comtex SmarTrend(R) - Mon Dec 01, 3:45PM CST
iShares MSCI Brazil Index Fund (NYSE:EWZ) traded in a range yesterday that spanned from a low of $39.83 to a high of $40.89. Yesterday, the shares fell 4.1%, which took the trading range below the 3-day low of $41.66 on volume of 34.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
EWZ: 39.13 (-0.74)

iShares MSCI Brazil Index Fund Set to Possibly Rebound After Yesterday's Selloff of 4.13%
Comtex SmarTrend(R) - Mon Dec 01, 3:44PM CST
iShares MSCI Brazil Index Fund (NYSE:EWZ) traded in a range yesterday that spanned from a low of $39.83 to a high of $40.89. Yesterday, the shares fell 4.1%, which took the trading range below the 3-day low of $41.66 on volume of 34.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
EWZ: 39.13 (-0.74)

The Periodic Table Of Emerging Markets 2004 To 2013
David Hunkar - at Seeking Alpha - Mon Dec 01, 12:26PM CST
The U.S. equity market has performed well so this year with only one more month left to go. As of November end, the S&P 500 is up by 11.9% based on price returns and the Dow is up by 7.6%. Among the emerging markets, India is the top performer...
EWW: 61.96 (-0.52), EZA: 66.73 (-0.85), INDY: 31.84 (+0.09), RSX: 18.66 (-0.51), EWZ: 39.13 (-0.74), FXI: 41.51 (+1.21)

iShares MSCI Brazil Index Fund (EWZ)
Trading Central - Mon Dec 01, 12:24PM CST
The iShares MSCI Brazil Index Fund (EWZ) has reached our stop loss which was set at $40.90 . Performance: -6.41%.
EWZ: 39.13 (-0.74)

Brazilian Stock Market: New Finance Minister Brings New Hopes, But Problems Still Remain
Peter Arendas - at Seeking Alpha - Sat Nov 29, 12:21PM CST

PBR: 8.91 (-0.36), VALE: 8.35 (-0.18), EWZ: 39.13 (-0.74)

Brazil escapes from recession ... barely
Seeking Alpha - at Seeking Alpha - Fri Nov 28, 7:01AM CST

PBR: 8.91 (-0.36), EWZ: 39.13 (-0.74)

Watch This Brazilian ETF Following The Petrobras Scandal
Zacks Funds - at Seeking Alpha - Tue Nov 25, 11:22PM CST
Originally published on November 24, 2014 Brazilian state-run energy giant Petroleo Brasileiro S.A., or Petrobras (NYSE: PBR ), which was expected to release its third-quarter 2014 results on November 14, shocked the investing world by putting...
PBR: 8.91 (-0.36), EWZ: 39.13 (-0.74)

Report: Joaquim Levy named as Brazil Finance Minister
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 11:31AM CST

FBZ: 16.61 (-0.41), BRZS: 32.02 (+0.64), BZQ: 75.04 (+2.60), BRZU: 10.73 (-0.63), BRAF: 9.90 (-0.18), UBR: 32.40 (-1.35), DBBR: 13.65 (-0.21), BSBR: 5.51 (-0.22), EWZS: 15.44 (-0.26), PBR: 8.91 (-0.36), BBD: 14.20 (-0.30), BRXX: 12.38 (-0.31), BRAZ: 11.04 (-0.30), VALE: 8.35 (-0.18), GOL: 5.37 (+0.08), BRF: 23.80 (-0.27), EWZ: 39.13 (-0.74), ITUB: 14.05 (-0.19), BRAQ: 15.12 (-0.42)

iShares MSCI Brazil Index Fund (EWZ) : Buy @ $43.7
Trading Central - Tue Nov 25, 8:30AM CST
# TECHNICAL VIEW # (Daily chart) *a key support are has formed at appx $38.40, support given by the lows of February, October and November 2014. *the iShares MSCI Brazil Index Fund has broken above a declining line on large volume *the double bottom...
EWZ: 39.13 (-0.74)

Between A Rock And A Hard Place: Outlook For Brazil
Russ Koesterich, CFA - Seeking Alpha - Tue Nov 25, 3:04AM CST
Although Brazil may look undervalued, many factors keep us from having a more optimistic view of the country. Investors in Brazil have had the dubious pleasure of undergoing one of the more stomach-churning rides in 2014. In U.S.-dollar terms,...
FBZ: 16.61 (-0.41), BRZS: 32.02 (+0.64), BZQ: 75.04 (+2.60), BRZU: 10.73 (-0.63), UBR: 32.40 (-1.35), DBBR: 13.65 (-0.21), EWZ: 39.13 (-0.74)

Watch This Brazilian ETF Following the Petrobras Scandal - ETF News And Commentary
Zacks Equity Research - ZACKS - Mon Nov 24, 9:00AM CST
Petrobras delayed its earnings release and is in the midst of a scandal. This news could hit the EWZ ETF hard.
1 Comment
PBR: 8.91 (-0.36), EWZ: 39.13 (-0.74)

The Path Matters More Than The Destination
Michael A. Gayed, CFA - Seeking Alpha - Mon Nov 24, 7:19AM CST
"Two roads diverged in a wood and I - I took the one less traveled by, and that has made all the difference." - Robert Frost Whenever I see headlines that read "stocks hit new highs," I tend to cringe. Stocks are not hitting new...
EWG: 28.50 (-0.07), SPY: 207.66 (-0.23), EWQ: 26.04 (-0.09), IWM: 116.81 (-0.56), EWZ: 39.13 (-0.74), FXI: 41.51 (+1.21)

Weekly ETF Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 21, 3:21PM CST

GDXJ: 25.69 (-0.63), VXX: 26.54 (+0.02), URA: 12.42 (-0.14), FXY: 81.27 (unch), EWA: 23.54 (+0.06), GAZ: 2.15 (-0.08), BRF: 23.80 (-0.27), ILF: 33.71 (-0.58), EWZ: 39.13 (-0.74), FXI: 41.51 (+1.21)

Brazilian stocks pop as bank executive among finance minister finalists
Seeking Alpha - at Seeking Alpha - Fri Nov 21, 9:06AM CST

FBZ: 16.61 (-0.41), BRZS: 32.02 (+0.64), BZQ: 75.04 (+2.60), BRZU: 10.73 (-0.63), BRAF: 9.90 (-0.18), UBR: 32.40 (-1.35), DBBR: 13.65 (-0.21), BSBR: 5.51 (-0.22), EWZS: 15.44 (-0.26), PBR: 8.91 (-0.36), BBD: 14.20 (-0.30), BRXX: 12.38 (-0.31), BRAZ: 11.04 (-0.30), VALE: 8.35 (-0.18), GOL: 5.37 (+0.08), BRF: 23.80 (-0.27), EWZ: 39.13 (-0.74), ITUB: 14.05 (-0.19), BRAQ: 15.12 (-0.42)

Contrarian Perspective: Are Brazil ETFs Now A Buy?
Matthew Sauer, Esq. - at Seeking Alpha - Thu Nov 20, 11:58AM CST

DBBR: 13.65 (-0.21), BRF: 23.80 (-0.27), EWZ: 39.13 (-0.74)

SmarTrend Watching for Potential Pullback in Shares of iShares MSCI Brazil Index Fund After 2.92% Gain
Comtex SmarTrend(R) - Wed Nov 19, 3:40PM CST
iShares MSCI Brazil Index Fund (NYSE:EWZ) traded in a range yesterday that spanned from a low of $39.89 to a high of $41.10. Yesterday, the shares gained 2.9%, which took the trading range above the 3-day high of $39.96 on volume of 26.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EWZ: 39.13 (-0.74)

iShares MSCI Brazil Index Fund Set to Possibly Pullback After Yesterday's Rally of 2.92%
Comtex SmarTrend(R) - Wed Nov 19, 3:40PM CST
iShares MSCI Brazil Index Fund (NYSE:EWZ) traded in a range yesterday that spanned from a low of $39.89 to a high of $41.10. Yesterday, the shares gained 2.9%, which took the trading range above the 3-day high of $39.96 on volume of 26.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EWZ: 39.13 (-0.74)

Nomura: Brazilian economy unraveling
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 2:09PM CST

FBZ: 16.61 (-0.41), BRZS: 32.02 (+0.64), BRZU: 10.73 (-0.63), BZQ: 75.04 (+2.60), BRAF: 9.90 (-0.18), UBR: 32.40 (-1.35), DBBR: 13.65 (-0.21), EWZS: 15.44 (-0.26), BRXX: 12.38 (-0.31), BRAZ: 11.04 (-0.30), BRF: 23.80 (-0.27), EWZ: 39.13 (-0.74), BRAQ: 15.12 (-0.42)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 3

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 6

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 5

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 0

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 0

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 1

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched: Are SecureWorks Shareholders Treated Fairly?

Updated Category News Views 58

Investigation Into SecureWorks Corp. Shareholder Fairness In recent developments, Ademi LLP has initiated an investigation into SecureWorks Corp. (NASDAQ: SCWX) concerning possible breaches of fiduciary duty related to its upcoming transaction with Sophos. This investigation raises important questions about whether SecureWorks is providing fair value to its public...

Continue Reading
VIAVI Partners with Telefónica HISPAM for Network Solutions

Updated Category News Views 94

VIAVI Partners with Telefónica HISPAM for Enhanced Network Management Viavi Solutions Inc. (VIAVI) (NASDAQ: VIAV) recently secured a strategic agreement to provide advanced automated network inventory management for Telefónica Hispanoamérica (HISPAM). This collaboration aims to leverage Viavi's innovative NITRO AIOps solution to improve network operations throughout...

Continue Reading
Crédit Agricole Assurances Reports Remarkable Growth in 2024

Updated Category News Views 68

Crédit Agricole Assurances Reports Remarkable Growth in 2024 Crédit Agricole Assurances recently revealed their impressive performance for the first nine months of 2024, showcasing an 18.2% increase in total revenue, amounting to €32.8 billion. This significant growth reflects the company's dedication to its clients and the effectiveness of its diverse insurance...

Continue Reading
Teads Holding Co. Announces Participation in Key Conferences

Updated Category News Views 135

Teads Holding Co. Engages Investors in Upcoming Conferences Teads Holding Co. (NASDAQ: TEAD), recognized as a leader in the advertising technology space, is gearing up for significant investor conferences this September. As the company continues to expand its influence and reach, it will showcase its innovative approach to marketing solutions at these events, emphasizing...

Continue Reading
Intelligent Vending Machines Market Growth Predictions

Updated Category News Views 68

Overview of the Intelligent Vending Machines Market The Intelligent Vending Machines market is undergoing rapid transformation, capturing the interest of both investors and consumers alike. As technology progresses at an astonishing pace, these machines are evolving from simple snack dispensers into advanced retail solutions. Currently valued at USD 22.15 billion, the...

Continue Reading